Africa: Access Planning for Ebola Medicines Moves Ahead During Clinical Trials
Unitaid welcomes Gilead’s announcement of royalty-free voluntary licensing agreements with Dr. Reddy’s Laboratories, Eva Pharma and Ferozsons Laboratories. The agreements lay the groundwork for wider access to obeldesivir, an investigational antiviral being studied to prevent Ebola Bundibugyo virus disease (BVD). If clinical evidence supports its use and regulators approve it, the three manufacturers across different…
